drugset / Trial / NCT03757897

The Influence of Dexmedetomidine Hypnosis on Cerebrospinal Fluid (CSF) Volume, Brain Diffusion and 'Stiffness' Characteristics.

NCT03757897 ↗

Phase 0 Withdrawn Yale University
NaSingle-groupOpen-labelDiagnostic

Summary

The primary goal is to quantify cerebrospinal fluid (CSF) volume, diffusion characteristics and mechanical properties of brain tissue at two states of arousal.

Timeline

Start
2021-12
Primary completion
2022-12
Completion
2022-12

Outcome

Outcome not reported

Stopped: “The investigators were unable to implement a MRI compatible EEG for use in human subjects (equipment and technical issues).”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified — Intravenous